![Donald Wuchterl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald Wuchterl
Direktor/Vorstandsmitglied bei
ABEONA THERAPEUTICS INC.
Vermögen: 970 664 $ am 31.05.2026
Profil
Donald A. Wuchterl currently works at Abeona Therapeutics, Inc., as Independent Director from 2021.
Mr. Wuchterl also formerly worked at Astellas Gene Therapies, Inc., as Senior VP-Technical Operations & Quality from 2016 to 2021, Cytovance Biologics, Inc., as Chief Operating Officer & Senior Vice President from 2012 to 2016, and T-Knife Therapeutics, Inc., as Senior VP & Chief Manufacturing Officer from 2021 to 2022.
Mr. Wuchterl received his undergraduate degree from Colorado Technical University, Inc. and Masters Business Admin degree from Fitchburg State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2026 | 167’935 ( 0.29% ) | 970 664 $ | 31.05.2026 |
Aktive Positionen von Donald Wuchterl
| Unternehmen | Position | Beginn |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 19.04.2021 |
Ehemalige bekannte Positionen von Donald Wuchterl
| Unternehmen | Position | Ende |
|---|---|---|
T-Knife Therapeutics, Inc.
 T-Knife Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that dedicated to developing novel therapeutics to fight cancer and provides T cell therapy services | Corporate Officer/Principal | 01.08.2022 |
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2021 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Geschäftsführer | 01.01.2016 |
Ausbildung von Donald Wuchterl
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
25
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Health Technology |
Colorado Technical University, Inc.
 Colorado Technical University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fitchburg State University
 Fitchburg State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
T-Knife Therapeutics, Inc.
T-Knife Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that dedicated to developing novel therapeutics to fight cancer and provides T cell therapy services | Health Technology |
Wählen Sie MarketScreener 
